Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of efficacy of 5% calcium sodium phosphosilicate and 8% arginine and calcium carbonate in reducing dentin hypersensitivity following non-surgical periodontal therapy
TCTR20180611003Phase 2Completed
- Sponsor
- Faculty of Dentistry, Chulalongkorn University
- Start
- Sep 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of calcium sodium phosphosilicate, arginine, calcium carbonate in Dentinal hypersensitivity (DH), sponsored by Faculty of Dentistry, Chulalongkorn University. Started Sep 2018; status: completed.
02
Drugs
calcium sodium phosphosilicateargininecalcium carbonate
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on TCTR20180611003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180611003.